Homocysteine, stroke, and dementia.
- 1 October 2002
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 33 (10), 2343-4
- https://doi.org/10.1161/01.str.0000032551.95449.2a
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or StrokeCerebrovascular Diseases, 2002
- Homocysteine and Cognitive Decline in Healthy ElderlyDementia and Geriatric Cognitive Disorders, 2001
- Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and DesignNeuroepidemiology, 2001
- Hyperhomocysteinemia in dementiaJournal of Neural Transmission, 2000
- Broadsheet number 58: homocysteine and diseasePathology, 2000
- Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer DiseaseArchives of Neurology, 1998
- Homocysteine and AtherothrombosisNew England Journal of Medicine, 1998